Discover a new way to find and share stories you'll love… Learn about Reading Desk

Trend Results : Kettering Cancer Center


Blog Post Results (1-20 of 35)

FILTER RESULTS

The Newest Precision Medicine Tool: Prostate Cancer Organoids

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test cancer drugs and personalize cancer treatment.

Bernie Madoff’s son, Andrew, dies of lymphoma at age 48

Andrew Madoff died at Sloan Kettering Cancer Center, his lawyer told CNBC. Andrew was never charged criminally as part of his father's multi-billion dollar Ponzi scheme.

‘Second Opinion: Laetrile at Sloan-Kettering’: Movie Review

Eric Merola, director of two documentaries about the controversial cancer doctor Stanislaw Burzynski, now sets his sights on the internal cover-up of positive results for Laetrile at the Memorial Sloan Kettering Cancer Center in the 1970s.

Memorial Sloan Kettering Ranks First in the Nation for Cancer Care

Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.

Memorial Sloan Kettering Appoints Digitaslbi as Digital Agency of Record

Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK's digital reach.

Teens surviving cancer get special graduation at Memorial Sloan Kettering Cancer Center

They overcame the worst that life can throw at a kid - cancer and its debilitating surgeries, fatigue, vomiting and depression.

Memorial Sloan Kettering Cancer Center and Quest Diagnostics Partner to Advance Precision Medicine in Cancer Diagnosis and Treatment

Memorial Sloan Kettering Cancer Center and Quest Diagnostics announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors. The goal is to use molecular laboratory...Show More Summary

Landmark Gift of $100 Million from the Marie-Josee and Henry R. Kravis Foundation Will Support Groundbreaking Approach to Precision Oncology

Memorial Sloan Kettering Cancer Center launched the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, an ambitious initiative to improve cancer care and research through genomic analysis.

Paying It Forward: Breakthrough Prize Winners and Institutions Commit $3 Million in Support of Next Generation of Scientists

Three winners of the first-ever Breakthrough Prizes-- Charles L. Sawyers, MD, of Memorial Sloan Kettering Cancer Center; Cornelia I. Bargmann, PhD, of the Rockefeller University; and Lewis C. Cantley, PhD, of Weill Cornell Medical College...Show More Summary

DigitasLBi Takes on Memorial Sloan Kettering

We’ve been told that this has transpired in a matter of the last 24 hours, but yes, DigitasLBi has  been appointed as agency partner for Memorial Sloan Kettering, the 130-year-old private cancer center based in NYC. We’ve been told that work for the center will be handled out of the New York and Boston DigitasLBi offices. Show More Summary

Researchers discover unusual genetic mutation linked to adolescent liver cancer

In the race for better treatments and possible cures, rare diseases are often left behind. In a collaboration of researchers at The Rockefeller University, Memorial Sloan Kettering Cancer Center and the New York Genome Center (NYGC), an unusual mutation has been found that is strongly linked to one such disease: a rare liver cancer that affects teens and young adults. read more

Genetically modified T cells induced complete remissions in 88 percent of advanced leukemia patients treated

Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment. The largest clinical study ever conducted to date of patients with advanced leukemia...Show More Summary

Cell therapy shows remarkable ability to eradicate cancer in clinical study

NEW YORK, February 19, 2014 — Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to...Show More Summary

Newly Engineered Monoclonal Antibody Shows Promise, Moves Toward Clinical Testing

Memorial Sloan Kettering Cancer Center and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.

IBM’s Watson Now Tackles Clinical Trials At MD Anderson Cancer Center

11 months agoTechnology : Tradigital

IBM continues to expand the use of its Watson supercomputer from winning Jeopardy to handling incoming call-center questions to guiding cancer doctors at Memorial Sloan Kettering to better diagnoses. Today it announced a new pilot program for Watson at Houston’s renowned MD Anderson Cancer Center. The institution has been trying out Watson for a little [...]

New radiation therapy technology takes weeks off of lung cancer treatments - Elekta's Versa HD™

12 months agoHealth : Medical News Today

On September 4, Kettering Medical Center (Kettering, Ohio) became the first clinic in North America to use Elekta's Versa HD™ system to treat a patient, a 71-year-old woman with medically inoperable lung cancer. The rapid speed of radiosurgery...Show More Summary

IBM’s Watson for “important” decisions where you need an advisor

2 years agoTechnology : GigaOM

IBM’s Watson will team up with Memorial Sloan Kettering this fall and plans to launch in a handful of cancer care centers this year, but Dan Cerutti, IBM’s GM of Watson Commercialization, said today at GigaOM Structure that Watson could be used in other fields too. [...]

Tumors Start To Develop As A Result Of Specific Combinations Of Errors In The Processes That Safeguard Cell Integrity

A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors...

Researchers at IRB Barcelona uncover new clues about the origin of cancer

A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors. read more

A Judge's Plea for Pot

Gustin L. Reichbach: This is not a law-and-order issue; it is a medical and a human rights issue. Being treated at Memorial Sloan Kettering Cancer Center, I am receiving the absolute gold standard of medical care. But doctors cannot be expected to do what the law prohibits, even when they know it is in the best interests of their patients. Show More Summary

Copyright © 2011 Regator, LLC